Skip to main content
OpenTrials

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

6,011 public trials 1,222 recruiting studies
Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Completed

Gossypol in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme

NCT00540722

Conditions
Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, +19 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View Trial Details
Completed

Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy

NCT01156142

Conditions
Carcinoma, Carcinoma, Squamous Cell, Cranial Nerve Diseases, +33 more
Locations
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center Hartford, Connecticut, United States
  • Mayo Clinic - Jacksonville Jacksonville, Florida, United States
  • MBCCOP - Medical College of Georgia Cancer Center Augusta, Georgia, United States
View all 120 locations
View Trial Details
Completed

p28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System Tumors

NCT01975116

Conditions
Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Astrocytoma, +28 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Lurie Children's Hospital-Chicago Chicago, Illinois, United States
View Trial Details
Completed

Anti-Tumor Activity Of SB-485232 In Patients With Previously Untreated Metastatic Melanoma

NCT00107718

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site San Francisco, California, United States
  • GSK Investigational Site Santa Monica, California, United States
  • GSK Investigational Site New Haven, Connecticut, United States
View all 20 locations
View Trial Details
Completed

Erlotinib Compared With Temozolomide or Carmustine in Treating Patients With Recurrent Glioblastoma Multiforme

NCT00086879

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +16 more
Locations
  • U.Z. Gasthuisberg Leuven, Belgium
  • Centre de Lutte Contre le Cancer Georges-Francois Leclerc Dijon, France
  • Centre Regional Rene Gauducheau Nantes-Saint Herblain, France
  • Centre Antoine Lacassagne Nice, France
View Trial Details

Related conditions